WCG’s end-to-end patient recruitment solution connects patients to clinical trials, enhances site resources and capabilities, and improves study data quality and endpoints. On average, we are helping our clients achieve a 33% acceleration in their enrollment timelines.
SynteractHCR offers full-featured global Interactive Voice and Web Response Systems for your clinical trial operations, through our validated 21 CRF Part 11 compliant proprietary system. Once implemented, the system is available 24/7 for use by sites, study participants and project team members. Transactions are recorded into a study-specific database, and information can be exported into custom reports. Live technical support is available to sites and study participants via phone, email or web access. SynteractHCR has successfully implemented IWRS in 30 countries and has the capability to translate 26 different languages.
Aseptic sampling devices are a critical component in an effective microbial control program. Samples collected with TAKEONE® are used to measure critical purity attributes such as bioburden, sterility and endotoxin levels and important process parameters like metabolites, nutrients, osmolality, pH and more. The TAKEONE® aseptic sampling device is a pre-assembled and single-use sampling solution. The 1,5" or 2" device has 5 or 9 fully-closed and independent sampling lines. TAKEONE® collects perfectly representative samples giving exact results with no risk of false positives.
Corry Micronics can be your RF systems packaging integrator.
ViskoTeepak and TOMRA Sorting Food decided to join forces in order to develop a casing solution that would make it easier for mini-salami producers to detect pieces of casing in peeling operations, while still being able to track the color formation of the sausage during processing. The result of this synergy is a completely new patent pending innovation in the world of casing and mini-salami casing detection.
The Research Foundation of the City University of New York (RF-CUNY) serves the nation’s largest urban public university, and manages grant awards exceeding $410 million in areas ranging from research in the natural and social sciences, training, job placement, curriculum planning, assessment, program evaluation, media production, and software development. The foundation has roughly 12,000 employees who serve in a variety of functions throughout CUNY’s 24 colleges, professional schools and off campus sights. The RF’s main function is to offer flexibility and respond quickly to the changing conditions and requirements of its many sponsors.
In the pharmaceutical and biopharmaceutical industry several factors have converged to change the landscape in regard to facilities.
Experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.
One way to lower the suspension viscosity of a drug is through the use of highly-concentrated crystalline suspensions, or protein crystals.
Purpose-built SSU solutions track clinical trial operations using much needed standardized performance metrics.
While the wider use of opioids has led to many benefits for patients in pain, it also has led to higher incidences of misuse, abuse, and development of opioid addiction.
Unlikely or unforeseen competitors continue to disrupt industries at an exponential pace. The innovation disruptors bring requires a key strategy: put the customer at the center of your business and deliver great experiences to them. Understand how consistent, timely, relevant and personalized experiences are enabled by having the right technology foundation in place.
Affordable housing developer Dominium is in the process of doubling in size, with plans for 40,000 units by 2025. Yet a manual, time-intensive work order-management and apartment inspection process hampered field staff. The company set out to ratchet up operational efficiency and worker productivity in a bid to deliver enhanced service to its residents at a faster clip.
As Pfizer began its pursuit of delivering two biosimilar monoclonal antibodies (mAbs) in China, it sought a partner that could mitigate the risks of expanding into this region while also significantly reducing the development timeline. By leveraging the expertise of an experienced partner and the benefits of single-use technology (SUT), Pfizer was able to quickly establish a global footprint while also gaining a competitive advantage in an emerging market.
The competition is fierce in the business process outsourcing (BPO) space. That’s why the benefits that DATAMARK is achieving for a major client with an ibml image and data capture solution are so impressive. The solution has helped DATAMARK reduce its labor requirements by more than 50 percent, accelerate delivery of information downstream, and decrease its overhead.
Gilead Sciences’ previous studies of Ranexa (ranolazine) relied on data from exercise treadmill parameters as the primary endpoint. But collecting data in this manner is costly, logistically challenging, and bears questionable clinical relevance — especially at the individual patient level. Learn how Gilead Sciences successfully utilized ERT handhelds to collect regulatory-compliant, patient-driven data in support of the primary efficacy endpoint in a Phase IV study of Ranexa.
Fisher Clinical Services was contacted in early 2013 by a virtual biotech that had a set of unique challenges. With just one compound in the pipeline, the company was in trouble because its previous vendor made drug supply errors that compromised patient safety in Phase II. Not only was the clinical team navigating the ethics investigation triggered by this violation of trust, the legal team was fending off lawsuits from investors.
At the largest treatment plant of its kind in the world, it’s no surprise perhaps that they use some of the biggest grit classifiers available, with the final two of 16 newly installed units now commencing operation.
Kura Oncology, Inc., (Nasdaq:KURA) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported positive, preliminary results from a Phase 2 clinical study of its lead candidate tipifarnib in patients with chronic myelomonocytic leukemia (CMML).
Biopharmaceuticals are biological preparations which are intended to treat range of diseases. The market for biopharmaceuticals is robust with the availability of several biologics, biosimilars, and biobetters in the market.
Researchers at the University of Sheffield have solved a key puzzle in quantum physics that could help to make data transfer totally secure.
Researchers have demonstrated, for the first time, that an optical analysis method can reveal weak areas in ceramic thermal barrier coatings that protect jet engine turbines from high temperatures and wear